ARCHIVES

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997

Hamburg Confirmed As FDA Commissioner

May 22, 2009

Funding opportunities listed.

October 17, 2003

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001